Prospective Study on Esophageal and Gastric Endoscopic Submucosal Dissection Using a New Thin Scope EG-840TP
Not Applicable
- Conditions
- superficial carcinoma of the esophagus or early gastric cancer
- Registration Number
- JPRN-UMIN000053484
- Lead Sponsor
- Sendai Open Hospital, Sendai Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who are allergic to propofol, pentazocine, or lidocaine. Patients who are allergic to propofol, pentazocine, or lidocaine. Pregnant or lactating patients.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percentage of patients who complete treatment without changing from EG-840TP to another scope (completion rate).
- Secondary Outcome Measures
Name Time Method Treatment time per site, number of hemostats used, en bloc resection rate, en bloc complete resection rate, scope questionnaire, sedative and analgesic doses during ESD, incidence of adverse events (perforation, posterior hemorrhage).